Loading…
Deletion of IL-17ra in osteoclast precursors increases bone mass by decreasing osteoclast precursor abundance
•Conditional deletion of IL-17ra in LysM+ osteoclast precursors increases trabecular bone mass in young, unchallenged mice.•IL-17ra deletion in pre-osteoclasts decreases osteoclast number and activity in vivo.•Conditional deletion of IL-17ra decreases the abundance of bone marrow-derived osteoclast...
Saved in:
Published in: | Bone (New York, N.Y.) N.Y.), 2022-04, Vol.157, p.116310-116310, Article 116310 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3710-76c5fc78d856d8ceedd57718b6d96bf56d505ab4dc77a262dc37e63f3be10b6d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c3710-76c5fc78d856d8ceedd57718b6d96bf56d505ab4dc77a262dc37e63f3be10b6d3 |
container_end_page | 116310 |
container_issue | |
container_start_page | 116310 |
container_title | Bone (New York, N.Y.) |
container_volume | 157 |
creator | Roberts, Joseph L. Mella-Velazquez, Giovanni Dar, Hamid Y. Liu, Guanglu Drissi, Hicham |
description | •Conditional deletion of IL-17ra in LysM+ osteoclast precursors increases trabecular bone mass in young, unchallenged mice.•IL-17ra deletion in pre-osteoclasts decreases osteoclast number and activity in vivo.•Conditional deletion of IL-17ra decreases the abundance of bone marrow-derived osteoclast progenitor populations.
Metabolic bone diseases, such as osteoporosis, typically reflect an increase in the number and activity of bone-resorbing osteoclasts that result in a loss of bone mass. Inflammatory mediators have been identified as drivers of both osteoclast formation and activity. The IL-17 family of inflammatory cytokines has gained attention as important contributors to both bone formation and resorption. The majority of IL-17 cytokines signal through receptor complexes containing IL-17a receptor (IL-17ra); however, the role of IL-17ra signaling in osteoclasts remains elusive. In this study, we conditionally deleted Il17ra in osteoclast precursors using LysM-Cre and evaluated the phenotypes of skeletally mature male and female conditional knockout and control mice. The conditional knockout mice displayed an increase in trabecular bone microarchitecture in both the appendicular and axial skeleton. Assessment of osteoclast formation in vitro revealed that deletion of Il17ra decreased osteoclast number, which was confirmed in vivo using histomorphometry. This phenotype was likely driven by a lower abundance of osteoclast precursors in IL-17ra conditional knockout mice. This study suggests that IL-17ra signaling in preosteoclasts can contribute to osteoclast formation and subsequent bone loss. |
doi_str_mv | 10.1016/j.bone.2021.116310 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10084774</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S8756328221004762</els_id><sourcerecordid>2615920803</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3710-76c5fc78d856d8ceedd57718b6d96bf56d505ab4dc77a262dc37e63f3be10b6d3</originalsourceid><addsrcrecordid>eNp9UU1LAzEUDKJorf4BD7JHL1vz0U1SEETqJxS86Dlkk7c1ZXdTk91C_72praIgHkLy3puZF2YQOiN4RDDhl4tR6VsYUUzJiBDOCN5DAyIFy6ngbB8NpCh4zqikR-g4xgXGmE0EOURHbDwR6dABam6hhs75NvNV9jTLiQg6c6mKHXhT69hlywCmD9GHmAYmgI4Qs83mrNExvdaZhc-2a-d_8jJd9q3VrYETdFDpOsLp7h6i1_u7l-ljPnt-eJrezHLDBMG54KaojJBWFtxKA2BtIQSRJbcTXlapWeBCl2NrhNCUU5towFnFSiA4gdgQXW91l33ZgDXQdkHXahlco8Naee3U70nr3tTcrxTBWI6FGCeFi51C8O89xE41Lhqoa92C76OinBQTiiVmCUq3UBN8jAGq7z0Eq01QaqE2dqlNUGobVCKd__zhN-UrmQS42gIg-bRyEFQ0DpKH1iVfO2W9-0__A68ep2w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2615920803</pqid></control><display><type>article</type><title>Deletion of IL-17ra in osteoclast precursors increases bone mass by decreasing osteoclast precursor abundance</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Roberts, Joseph L. ; Mella-Velazquez, Giovanni ; Dar, Hamid Y. ; Liu, Guanglu ; Drissi, Hicham</creator><creatorcontrib>Roberts, Joseph L. ; Mella-Velazquez, Giovanni ; Dar, Hamid Y. ; Liu, Guanglu ; Drissi, Hicham</creatorcontrib><description>•Conditional deletion of IL-17ra in LysM+ osteoclast precursors increases trabecular bone mass in young, unchallenged mice.•IL-17ra deletion in pre-osteoclasts decreases osteoclast number and activity in vivo.•Conditional deletion of IL-17ra decreases the abundance of bone marrow-derived osteoclast progenitor populations.
Metabolic bone diseases, such as osteoporosis, typically reflect an increase in the number and activity of bone-resorbing osteoclasts that result in a loss of bone mass. Inflammatory mediators have been identified as drivers of both osteoclast formation and activity. The IL-17 family of inflammatory cytokines has gained attention as important contributors to both bone formation and resorption. The majority of IL-17 cytokines signal through receptor complexes containing IL-17a receptor (IL-17ra); however, the role of IL-17ra signaling in osteoclasts remains elusive. In this study, we conditionally deleted Il17ra in osteoclast precursors using LysM-Cre and evaluated the phenotypes of skeletally mature male and female conditional knockout and control mice. The conditional knockout mice displayed an increase in trabecular bone microarchitecture in both the appendicular and axial skeleton. Assessment of osteoclast formation in vitro revealed that deletion of Il17ra decreased osteoclast number, which was confirmed in vivo using histomorphometry. This phenotype was likely driven by a lower abundance of osteoclast precursors in IL-17ra conditional knockout mice. This study suggests that IL-17ra signaling in preosteoclasts can contribute to osteoclast formation and subsequent bone loss.</description><identifier>ISSN: 8756-3282</identifier><identifier>EISSN: 1873-2763</identifier><identifier>DOI: 10.1016/j.bone.2021.116310</identifier><identifier>PMID: 34973492</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Bone Density ; Bone resorption ; Bone Resorption - metabolism ; Bone turnover ; Cytokine ; Cytokines - metabolism ; Female ; IL-17a ; Inflammation ; Interleukin-17 - genetics ; Male ; Mice ; Mice, Knockout ; Osteoclasts - metabolism</subject><ispartof>Bone (New York, N.Y.), 2022-04, Vol.157, p.116310-116310, Article 116310</ispartof><rights>2021 Elsevier Inc.</rights><rights>Copyright © 2021 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3710-76c5fc78d856d8ceedd57718b6d96bf56d505ab4dc77a262dc37e63f3be10b6d3</citedby><cites>FETCH-LOGICAL-c3710-76c5fc78d856d8ceedd57718b6d96bf56d505ab4dc77a262dc37e63f3be10b6d3</cites><orcidid>0000-0002-0268-5256 ; 0000-0001-6839-1173 ; 0000-0002-4018-4559</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34973492$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roberts, Joseph L.</creatorcontrib><creatorcontrib>Mella-Velazquez, Giovanni</creatorcontrib><creatorcontrib>Dar, Hamid Y.</creatorcontrib><creatorcontrib>Liu, Guanglu</creatorcontrib><creatorcontrib>Drissi, Hicham</creatorcontrib><title>Deletion of IL-17ra in osteoclast precursors increases bone mass by decreasing osteoclast precursor abundance</title><title>Bone (New York, N.Y.)</title><addtitle>Bone</addtitle><description>•Conditional deletion of IL-17ra in LysM+ osteoclast precursors increases trabecular bone mass in young, unchallenged mice.•IL-17ra deletion in pre-osteoclasts decreases osteoclast number and activity in vivo.•Conditional deletion of IL-17ra decreases the abundance of bone marrow-derived osteoclast progenitor populations.
Metabolic bone diseases, such as osteoporosis, typically reflect an increase in the number and activity of bone-resorbing osteoclasts that result in a loss of bone mass. Inflammatory mediators have been identified as drivers of both osteoclast formation and activity. The IL-17 family of inflammatory cytokines has gained attention as important contributors to both bone formation and resorption. The majority of IL-17 cytokines signal through receptor complexes containing IL-17a receptor (IL-17ra); however, the role of IL-17ra signaling in osteoclasts remains elusive. In this study, we conditionally deleted Il17ra in osteoclast precursors using LysM-Cre and evaluated the phenotypes of skeletally mature male and female conditional knockout and control mice. The conditional knockout mice displayed an increase in trabecular bone microarchitecture in both the appendicular and axial skeleton. Assessment of osteoclast formation in vitro revealed that deletion of Il17ra decreased osteoclast number, which was confirmed in vivo using histomorphometry. This phenotype was likely driven by a lower abundance of osteoclast precursors in IL-17ra conditional knockout mice. This study suggests that IL-17ra signaling in preosteoclasts can contribute to osteoclast formation and subsequent bone loss.</description><subject>Animals</subject><subject>Bone Density</subject><subject>Bone resorption</subject><subject>Bone Resorption - metabolism</subject><subject>Bone turnover</subject><subject>Cytokine</subject><subject>Cytokines - metabolism</subject><subject>Female</subject><subject>IL-17a</subject><subject>Inflammation</subject><subject>Interleukin-17 - genetics</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Osteoclasts - metabolism</subject><issn>8756-3282</issn><issn>1873-2763</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9UU1LAzEUDKJorf4BD7JHL1vz0U1SEETqJxS86Dlkk7c1ZXdTk91C_72praIgHkLy3puZF2YQOiN4RDDhl4tR6VsYUUzJiBDOCN5DAyIFy6ngbB8NpCh4zqikR-g4xgXGmE0EOURHbDwR6dABam6hhs75NvNV9jTLiQg6c6mKHXhT69hlywCmD9GHmAYmgI4Qs83mrNExvdaZhc-2a-d_8jJd9q3VrYETdFDpOsLp7h6i1_u7l-ljPnt-eJrezHLDBMG54KaojJBWFtxKA2BtIQSRJbcTXlapWeBCl2NrhNCUU5towFnFSiA4gdgQXW91l33ZgDXQdkHXahlco8Naee3U70nr3tTcrxTBWI6FGCeFi51C8O89xE41Lhqoa92C76OinBQTiiVmCUq3UBN8jAGq7z0Eq01QaqE2dqlNUGobVCKd__zhN-UrmQS42gIg-bRyEFQ0DpKH1iVfO2W9-0__A68ep2w</recordid><startdate>20220401</startdate><enddate>20220401</enddate><creator>Roberts, Joseph L.</creator><creator>Mella-Velazquez, Giovanni</creator><creator>Dar, Hamid Y.</creator><creator>Liu, Guanglu</creator><creator>Drissi, Hicham</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0268-5256</orcidid><orcidid>https://orcid.org/0000-0001-6839-1173</orcidid><orcidid>https://orcid.org/0000-0002-4018-4559</orcidid></search><sort><creationdate>20220401</creationdate><title>Deletion of IL-17ra in osteoclast precursors increases bone mass by decreasing osteoclast precursor abundance</title><author>Roberts, Joseph L. ; Mella-Velazquez, Giovanni ; Dar, Hamid Y. ; Liu, Guanglu ; Drissi, Hicham</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3710-76c5fc78d856d8ceedd57718b6d96bf56d505ab4dc77a262dc37e63f3be10b6d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>Bone Density</topic><topic>Bone resorption</topic><topic>Bone Resorption - metabolism</topic><topic>Bone turnover</topic><topic>Cytokine</topic><topic>Cytokines - metabolism</topic><topic>Female</topic><topic>IL-17a</topic><topic>Inflammation</topic><topic>Interleukin-17 - genetics</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Osteoclasts - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roberts, Joseph L.</creatorcontrib><creatorcontrib>Mella-Velazquez, Giovanni</creatorcontrib><creatorcontrib>Dar, Hamid Y.</creatorcontrib><creatorcontrib>Liu, Guanglu</creatorcontrib><creatorcontrib>Drissi, Hicham</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Bone (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roberts, Joseph L.</au><au>Mella-Velazquez, Giovanni</au><au>Dar, Hamid Y.</au><au>Liu, Guanglu</au><au>Drissi, Hicham</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Deletion of IL-17ra in osteoclast precursors increases bone mass by decreasing osteoclast precursor abundance</atitle><jtitle>Bone (New York, N.Y.)</jtitle><addtitle>Bone</addtitle><date>2022-04-01</date><risdate>2022</risdate><volume>157</volume><spage>116310</spage><epage>116310</epage><pages>116310-116310</pages><artnum>116310</artnum><issn>8756-3282</issn><eissn>1873-2763</eissn><abstract>•Conditional deletion of IL-17ra in LysM+ osteoclast precursors increases trabecular bone mass in young, unchallenged mice.•IL-17ra deletion in pre-osteoclasts decreases osteoclast number and activity in vivo.•Conditional deletion of IL-17ra decreases the abundance of bone marrow-derived osteoclast progenitor populations.
Metabolic bone diseases, such as osteoporosis, typically reflect an increase in the number and activity of bone-resorbing osteoclasts that result in a loss of bone mass. Inflammatory mediators have been identified as drivers of both osteoclast formation and activity. The IL-17 family of inflammatory cytokines has gained attention as important contributors to both bone formation and resorption. The majority of IL-17 cytokines signal through receptor complexes containing IL-17a receptor (IL-17ra); however, the role of IL-17ra signaling in osteoclasts remains elusive. In this study, we conditionally deleted Il17ra in osteoclast precursors using LysM-Cre and evaluated the phenotypes of skeletally mature male and female conditional knockout and control mice. The conditional knockout mice displayed an increase in trabecular bone microarchitecture in both the appendicular and axial skeleton. Assessment of osteoclast formation in vitro revealed that deletion of Il17ra decreased osteoclast number, which was confirmed in vivo using histomorphometry. This phenotype was likely driven by a lower abundance of osteoclast precursors in IL-17ra conditional knockout mice. This study suggests that IL-17ra signaling in preosteoclasts can contribute to osteoclast formation and subsequent bone loss.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34973492</pmid><doi>10.1016/j.bone.2021.116310</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-0268-5256</orcidid><orcidid>https://orcid.org/0000-0001-6839-1173</orcidid><orcidid>https://orcid.org/0000-0002-4018-4559</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 8756-3282 |
ispartof | Bone (New York, N.Y.), 2022-04, Vol.157, p.116310-116310, Article 116310 |
issn | 8756-3282 1873-2763 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10084774 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Animals Bone Density Bone resorption Bone Resorption - metabolism Bone turnover Cytokine Cytokines - metabolism Female IL-17a Inflammation Interleukin-17 - genetics Male Mice Mice, Knockout Osteoclasts - metabolism |
title | Deletion of IL-17ra in osteoclast precursors increases bone mass by decreasing osteoclast precursor abundance |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A57%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Deletion%20of%20IL-17ra%20in%20osteoclast%20precursors%20increases%20bone%20mass%20by%20decreasing%20osteoclast%20precursor%20abundance&rft.jtitle=Bone%20(New%20York,%20N.Y.)&rft.au=Roberts,%20Joseph%20L.&rft.date=2022-04-01&rft.volume=157&rft.spage=116310&rft.epage=116310&rft.pages=116310-116310&rft.artnum=116310&rft.issn=8756-3282&rft.eissn=1873-2763&rft_id=info:doi/10.1016/j.bone.2021.116310&rft_dat=%3Cproquest_pubme%3E2615920803%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3710-76c5fc78d856d8ceedd57718b6d96bf56d505ab4dc77a262dc37e63f3be10b6d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2615920803&rft_id=info:pmid/34973492&rfr_iscdi=true |